Unpacking sources of transmission in HIV prevention trials with deep-sequence pathogen data
Open Access
- 14 March 2026
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 17
Abstract
To develop effective HIV prevention strategies to guide public health policy the main sources of infection in HIV prevention studies must be identified. Accordingly, we devised a statistical approach that estimates the relative contribution of different sources of infection in community-randomized trials of infectious disease prevention using deep- (or next generation) sequenced pathogen data. We applied this approach to the Botswana Combination Prevention Project (BCPP) and estimated that 90% [95% Confidence Interval (CI): 80–94] of new infections in communities that received combination prevention (including universal HIV test-and-treat) originated from individuals residing in communities outside the trial area. We estimate from our model that the relative benefit of providing the BCPP intervention to all communities nationwide would be a 59% [3–87] reduction in transmissions to recipients in trial communities, exceeding the 30% reduction observed when providing the BCPP intervention to trial communities only. Our results suggest that the impact of the BCPP trial intervention was curtailed by sources of transmission outside the trial area and could be considerably larger if applied nationally. We recommend that the impact of sources of transmission beyond the reach of the intervention be considered when designing and evaluating interventions to inform public health programs.Keywords
This publication has 21 references indexed in Scilit:
- Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trialThe Lancet HIV, 2020
- What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?Journal of the International AIDS Society, 2020
- HIV-1 Epidemic Control — Insights from Test-and-Treat TrialsNew England Journal of Medicine, 2019
- Universal Testing, Expanded Treatment, and Incidence of HIV Infection in BotswanaNew England Journal of Medicine, 2019
- HIV Testing and Treatment with the Use of a Community Health Approach in Rural AfricaNew England Journal of Medicine, 2019
- Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART)New England Journal of Medicine, 2019
- Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysisNature Communications, 2019
- Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trialThe Lancet HIV, 2018
- Comparative assessment of five trials of universal HIV testing and treatment in sub‐Saharan AfricaJournal of the International AIDS Society, 2018
- Antiretroviral Therapy for the Prevention of HIV-1 TransmissionNew England Journal of Medicine, 2016